A novel agent enhances the chemotherapeutic efficacy of doxorubicin in MCF-7 breast cancer cells
We have previously demonstrated that DT-010, a novel conjugate of danshensu (DSS) and tetramethylpyrazine (TMP), displays antitumor effects in breast cancer cells both in vitro and in vivo. In the present study, we investigated whether DT-010 enhances the chemotherapeutic effect of doxorubicin (Dox)...
Saved in:
Main Authors: | Liang Wang (Author), Judy Yuet-Wa Chan (Author), Xinhua Zhou (Author), Guozhen Cui (Author), Zhixiang Yan (Author), Li Wang (Author), Ru Yan (Author), Lijun Di (Author), Yuqiang Wang (Author), Maggie Pui-Man Hoi (Author), Luchen Shan (Author), Simon M Y Lee (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of therapeutic effects of tetramethylpyrazine nitrone in Alzheimer's disease mouse model and proteomics analysis
by: Xinhua Zhou, et al.
Published: (2023) -
A Danshensu-Tetramethylpyrazine Conjugate DT-010 Overcomes Multidrug Resistance in Human Breast Cancer
by: Xinhua Zhou, et al.
Published: (2019) -
Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
by: Xu Wang, et al.
Published: (2019) -
Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
by: Xu Wang, et al.
Published: (2020) -
Hesperidin increase cytotoxic effect of doxorubicin in MCF-7 cells
by: Adam Hermawan, et al.
Published: (2010)